JPRN-UMIN000010474已完成未知
Effect of Insulin Degludec versus twice-daily administration of basal insulin in type 1 diabetes assessed by continuous glucose monitoring system - JUN-SIBA study:Juntendo-Soluble Insulin Basal Analogue study 2
Juntendo University Graduate School of Medicine0 个研究点目标入组 24 人开始时间: 2013年4月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with past medical history of hypersensitivity to Degludec. 2.Patients with serious liver,renal,pituitary and adrenal insufficiency. 3.Patients with diarrhea, vomiting and other gastrointestinal problems. 4.Patients with starvation state or unstable appetite. 5.Patients with serious diabetic complications including proliferative retinopathy. 6.Patients who are pregnant, hope to be pregnant, or are in lactation period. 7.Judged as ineligible by clinical investigators 8.Patients with type 1 diabetes
研究者
相似试验
已完成
不适用
Effects of Insulin Degludec versus Insulin Glargine in basal-bolus treatment in type 2 diabetes assessed by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010248Juntendo University Graduate School of Medicine30
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensificatioMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersDiabetes Mellitus, Type 2EUCTR2011-004665-32-GBovo Nordisk A/S320
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensification.Diabetes Mellitus Type 2MedDRA version: 15.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-004665-32-ITOVO NORDISK320
进行中（未招募）
不适用
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensificatioDiabetes Mellitus, Type 2EUCTR2011-004665-32-DEovo Nordisk A/S320
已完成
3 期
A trial to investigate the efficacy and safety of insulin degludec/liraglutide in subjects inadequately controlled with sulphonylurea alone or in combination with metformin.CTRI/2012/10/003039ovo Nordisk AS64